{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:08:43Z","timestamp":1776373723355,"version":"3.51.2"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Nebraska Foundation"},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 DA028555"],"award-info":[{"award-number":["P01 DA028555"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS36126"],"award-info":[{"award-number":["R01 NS36126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS31492"],"award-info":[{"award-number":["P01 NS31492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01 NS034239"],"award-info":[{"award-number":["2R01 NS034239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 MH64570"],"award-info":[{"award-number":["P01 MH64570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS43985"],"award-info":[{"award-number":["P01 NS43985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 MH062261"],"award-info":[{"award-number":["P30 MH062261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG043540"],"award-info":[{"award-number":["R01 AG043540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.antiviral.2015.05.009","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T08:40:40Z","timestamp":1432716040000},"page":"85-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice"],"prefix":"10.1016","volume":"120","author":[{"given":"Pavan","family":"Puligujja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariluz","family":"Ara\u00ednga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanta","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Palandri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Lee","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhi","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Poluektova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoEllyn","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.05.009_b0005","first-page":"3393","article-title":"Comparative manufacture and cell-based delivery of antiretroviral nanoformulations","volume":"6","author":"Balkundi","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.antiviral.2015.05.009_b0010","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1097\/QAD.0b013e328357f5ad","article-title":"Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice","volume":"26","author":"Dash","year":"2012","journal-title":"Aids"},{"key":"10.1016\/j.antiviral.2015.05.009_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nm0414-323","article-title":"Long-acting HIV drugs advanced to overcome adherence challenge","volume":"20","author":"Dolgin","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2015.05.009_b0020","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1128\/AAC.00267-13","article-title":"Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy","volume":"57","author":"Gautam","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.05.009_b0025","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/JVI.02010-06","article-title":"Human immunodeficiency virus type 1 pathobiology studied in humanized BALB\/c-Rag2\u2212\/\u2212gammac\u2212\/\u2212 mice","volume":"81","author":"Gorantla","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.009_b0030","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.jchromb.2011.06.032","article-title":"UPLC\u2013MS\/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues","volume":"879","author":"Huang","year":"2011","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.antiviral.2015.05.009_b0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11481-010-9198-7","article-title":"Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics","volume":"5","author":"Nowacek","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.antiviral.2015.05.009_b0040","first-page":"4","article-title":"Updated guideline to perform therapeutic drug monitoring for antiretroviral agents","volume":"2006","author":"la Porte","year":"2006","journal-title":"Rev. Antivir. Ther."},{"key":"10.1016\/j.antiviral.2015.05.009_b0045","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.nano.2013.05.003","article-title":"Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections","volume":"9","author":"Puligujja","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.antiviral.2015.05.009_b0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biomaterials.2014.11.012","article-title":"Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations","volume":"41","author":"Puligujja","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.antiviral.2015.05.009_b0055","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/infdis\/jis395","article-title":"Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice","volume":"206","author":"Roy","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.009_b0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jac\/dki235","article-title":"Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy","volume":"56","author":"Winston","year":"2005","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:49:42Z","timestamp":1589528982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":12,"alternative-id":["S0166354215001291"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}